Cyclacel Pharma (CYCC): Initiated Buy and $7 target at Roth Capital - 2010 Pivotal for CYCC
Tweet Send to a Friend
From Notable Calls
Roth Capital is initiating Cyclacel Pharma (NASDAQ: CYCC) with a Buy and $7 target saying 2010 is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital is initiating Cyclacel Pharma (NASDAQ: CYCC) with a Buy and $7 target saying 2010 is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
